FundedIQ
Biotechnology

Respira Technologies: Funding, Investors & Team (Sep 2026)

Respira Technologies is a stage gadget and biotechnology organization zeroing in on spray science. The organization is making advancement spray gadgets and plans that securely convey an expansive scope of drugs and nicotine. Respira Technologies' central goal is to make novel clinical gadgets of unrivaled proficiency and to propel the security of general wellbeing with purchaser gadgets through original advancement, mindful obtaining, draft administrative recommendations, straightforward item data, and sound judgment oversight.

respiratechnologies.com LinkedIn West Hollywood, United States 1-10 employees
Total raised
$360k
Rounds
1
Latest
Seed
Jul 2022

Respira Technologies has raised $360k across 1 funding round on record, the most recent a Seed of $360k announced in Jul 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Respira Technologies Company Profile and Key Stats

Total funding raised
$360k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$360k in Jul 2022
Employees
1-10
reported band
Headquarters
West Hollywood, United States

Latest funding round on record: Jul 2022.

Respira Technologies Funding Rounds

Date
Round
Amount
Seed
$360k

Respira Technologies Founders and Leadership Team

Name
Role
Contact
Mario Danek
CEO

No contact details are on record for this team yet.

Respira Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
16,664
$3.1M

Respira Technologies' latest round of $360k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Respira Technologies in Biotechnology and West Hollywood

Companies Similar to Respira Technologies

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Respira Technologies Funding FAQs

What does Respira Technologies do?

Respira Technologies is a stage gadget and biotechnology organization zeroing in on spray science. The organization is making advancement spray gadgets and plans that securely convey an expansive scope of drugs and nicotine. Respira Technologies' central goal is to make novel clinical gadgets of unrivaled proficiency and to propel the security of general wellbeing with purchaser gadgets through original advancement, mindful obtaining, draft administrative recommendations, straightforward item data, and sound judgment oversight.

How much funding has Respira Technologies raised?

Respira Technologies has raised $360k across 1 round on record. The most recent is a Seed of $360k announced in Jul 2022.

When did Respira Technologies last raise funding?

Respira Technologies' most recent funding round on record is a Seed of $360k, announced in Jul 2022.

Who is the CEO of Respira Technologies?

Mario Danek is listed as CEO at Respira Technologies.

Where is Respira Technologies headquartered?

Respira Technologies is based in West Hollywood, California, United States.

How many employees does Respira Technologies have?

Respira Technologies is in the 1-10 employee band.

How does Respira Technologies' funding compare to other Biotechnology startups?

Respira Technologies' latest round of $360k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Respira Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Respira Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.